BRPI0506066A - composição para doença aterosclerótica - Google Patents

composição para doença aterosclerótica

Info

Publication number
BRPI0506066A
BRPI0506066A BRPI0506066-4A BRPI0506066A BRPI0506066A BR PI0506066 A BRPI0506066 A BR PI0506066A BR PI0506066 A BRPI0506066 A BR PI0506066A BR PI0506066 A BRPI0506066 A BR PI0506066A
Authority
BR
Brazil
Prior art keywords
atherosclerotic disease
composition
therapeutic
compositions
treatment
Prior art date
Application number
BRPI0506066-4A
Other languages
English (en)
Inventor
Marcio Falci
Original Assignee
Biosintetica Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosintetica Farmaceutica Ltda filed Critical Biosintetica Farmaceutica Ltda
Priority to BRPI0506066-4A priority Critical patent/BRPI0506066A/pt
Priority to PCT/BR2006/000274 priority patent/WO2007068070A2/en
Publication of BRPI0506066A publication Critical patent/BRPI0506066A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO PARA DOENçA ATEROSCLERóTICA. A presente invenção revela uma associação farmacêutica útil no tratamento da doença aterosclerótica que compreende um inibidor específico da fosfodiesterase III e uma mistura alcoólica terapêutica, podendo incluir, opcionalmente, o ácido Acetil Salicílico em suas composições.
BRPI0506066-4A 2005-12-13 2005-12-13 composição para doença aterosclerótica BRPI0506066A (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0506066-4A BRPI0506066A (pt) 2005-12-13 2005-12-13 composição para doença aterosclerótica
PCT/BR2006/000274 WO2007068070A2 (en) 2005-12-13 2006-12-13 Composition containing an inhibitor of phosphodiesterase iii and a therapeutic alcohol for the treatment of atherosclerosis diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0506066-4A BRPI0506066A (pt) 2005-12-13 2005-12-13 composição para doença aterosclerótica

Publications (1)

Publication Number Publication Date
BRPI0506066A true BRPI0506066A (pt) 2007-10-02

Family

ID=37945450

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506066-4A BRPI0506066A (pt) 2005-12-13 2005-12-13 composição para doença aterosclerótica

Country Status (2)

Country Link
BR (1) BRPI0506066A (pt)
WO (1) WO2007068070A2 (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683116B1 (en) * 2003-01-31 2004-01-27 Unigen Pharmaceuticals, Inc. Polycosanols from Ericerus pela wax

Also Published As

Publication number Publication date
WO2007068070A2 (en) 2007-06-21
WO2007068070A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
CL2007003797A1 (es) Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades.
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
CR20110016A (es) Compuestos quimicos 251
CL2007002234A1 (es) Compuestos derivados de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
UY29983A1 (es) Derivados de 4-amino-pirrolotriazina sustituida utiles para el tratamiento de trastornos hiper-proliferativos y enfermedades asociadas con la angiogenesis
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
GT200900027A (es) Compuestos organicos
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
CL2007003138A1 (es) Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
BR0113661A (pt) Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
UY30460A1 (es) Compuestos terapéuticos
BRPI0903359B8 (pt) composição farmacêutica de metformina, ácido acetilsalicílico e composto de serotonina para o tratamento do câncer
BRPI0618479A2 (pt) pirrolpiridinas composição farmacêutica que as contém
CR10124A (es) Formulaciones orales que comprenden tigeciclina
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
UY29648A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A ANUI DADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.